Document Detail

Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.
MedLine Citation:
PMID:  20347079     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To compare the efficacy of Crinone vaginal gel and intramuscular progesterone (IMP) for luteal phase support in in vitro fertilization-embryo transfer (IVF-ET) with respect to pregnancy rates and outcomes, and to assess patient satisfaction with both products.
DESIGN: Prospective randomized trial.
SETTING: University-affiliated IVF unit.
PATIENT(S): Women under age 40 years with day-3 follicle-stimulating hormone levels <15 mIU/mL undergoing their first, second, or third IVF cycles on gonadotropin releasing-hormone (GnRH) down-regulation protocols.
INTERVENTION(S): Luteal phase supplementation with either Crinone vaginal gel or IMP; phone survey regarding patient satisfaction with Crinone vaginal gel and IMP.
MAIN OUTCOME MEASURE(S): Pregnancy rates, ongoing/delivered, failed pregnancy rates, and product satisfaction scores for patients supplemented with Crinone vaginal gel and with IMP.
RESULT(S): Four hundred sixty-eight patients were randomized, and 407 completed the study. The patients were randomized on the day of oocyte retrieval to receive either Crinone vaginal gel or IMP for luteal phase support. Pregnancy, ongoing/delivered, and failed pregnancy rates were similar between the Crinone and IMP treatment arms (OR [95% CI]: 1.2 [0.8, 1.8], 1.1 [0.8, 1.7], 1.0 [0.6, 1.7], respectively). On a scale of 1 to 5, patient satisfaction scores were statistically significantly higher with Crinone vaginal gel than with IMP (4.4 ± 0.9 vs. 2.8 ± 1.2).
CONCLUSION(S): Crinone vaginal gel and IMP are equally effective for luteal phase support in IVF, but Crinone is better tolerated by patients.
Elena Yanushpolsky; Shelley Hurwitz; Louise Greenberg; Catherine Racowsky; Mark Hornstein
Related Documents :
7061879 - Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid.
16390789 - Trends in the rate of shoulder dystocia over two decades.
15229009 - Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect o...
11755549 - Combined vaginal-cesarean delivery of twin pregnancies.
15512139 - Experience with selective external cephalic version at term in saudi arabia: a three ye...
8057069 - Pneumomediastinum and subcutaneous emphysema following vaginal delivery. case report an...
20656339 - Pregnancy-associated glycoprotein (pag) family localized in chorionic cells within the ...
24591899 - Misoprostol for termination of pregnancy-can it precipitate a seizure in a well control...
10886849 - Alcohol consumption and pregnancy in the mexican national addiction survey.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-03-27
Journal Detail:
Title:  Fertility and sterility     Volume:  94     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-26     Completed Date:  2011-01-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2596-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115-6114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Embryo Transfer* / methods
Fertilization in Vitro* / methods
Injections, Intramuscular
Luteal Phase / drug effects*
Patient Satisfaction
Pregnancy Rate
Progesterone / administration & dosage*,  adverse effects*,  analogs & derivatives*
Progesterone Congeners / administration & dosage,  adverse effects
Treatment Outcome
Vaginal Creams, Foams, and Jellies
Reg. No./Substance:
0/Crinone; 0/Progesterone Congeners; 0/Vaginal Creams, Foams, and Jellies; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hysteroscopic management of heterotopic cesarean scar pregnancy.
Next Document:  OCT4 gonadal gene expression related to the presence of Y-chromosome sequences in Turner syndrome.